Osteopenia Clinical Trial
Official title:
To Investigate the Efficacy and Mechanism of ZBP Powder Product in the Treatment of Osteopenia in Patients With Pain.
This study investigates the efficacy and mechanism of traditional Chinese medicine formula power product in the treatment of osteopenia in patients with pain. Half of participants will receive Chinese medicine formula power product, while the other half will receive a placebo.
Osteoporosis is a major public health problem, resulting in potentially pain and increasing
risk of fracture. Treatment of osteoporosis consists of pharmacotherapy, lifestyle measures,
dietary changes, mineral supplementation. Traditional Chinese medicine is a major component
of health care in Taiwan and provides one treatment alternative for osteoporosis.
Investigators investigate the efficacy and mechanism of traditional Chinese medicine formula
powder product in the treatment of osteopenia patients with pain.This trial is a 12 weeks'
randomized, placebo-controlled study. The study was approved by the Wan Fang hospital, and
signed informed consent was obtained from each participant. 80 Osteopenia participants with
pain were enrolled in this study. There were 80 participants aged 50 years or older included.
Before random assignment to treatment, participants were at least moderate pain during 2
weeks as identified by visual analogue scale (VAS) for more than 4. Bone mineral density
(BMD) of all participants was -2.5 or below without diabetes, hyperthyroidism,
hypoparathyroidism, liver or kidney function disorder, ovariectomy, rheumatoid arthritis,
bone cancer, ever used hormone agent within 6 months before assignment to treatment, ever
used steroids more than 3 week before assignment to treatment, Primary outcome measures were
the change of VAS scale, Oswestry Disability Index and WHOQOL-BREF Taiwan at week 1 and 12.
Secondary outcome was the genetic loci associated with a susceptibility to osteoprosis
treated by traditional Chinese medicine formula powder product.
Result : To provide evidence of the efficacy and mechanisms of ZBP powder product in the
treatment of osteoporosis patients with pain.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
Active, not recruiting |
NCT05066477 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Bone Mass Among Osteopenic Women
|
N/A | |
Terminated |
NCT01902186 -
Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
|
Phase 4 | |
Not yet recruiting |
NCT01397838 -
Safety Study of an Oral Pro-boneTM, Administered to Post Menopausal Osteopenic Women
|
Phase 1 | |
Completed |
NCT01439139 -
Bone UltraSonic Scanner (BUSS): Validation Study
|
N/A | |
Completed |
NCT01222026 -
Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
|
Phase 4 | |
Completed |
NCT01152580 -
Melatonin Osteoporosis Prevention Study
|
Phase 1 | |
Completed |
NCT00789425 -
Investigating the Effect of Standardized Olive Extract on Bone Turnover Markers in Postmenopausal Women
|
Phase 2 | |
Completed |
NCT00463268 -
Osteoporosis Prevention With Low Dose Alendronate
|
Phase 3 | |
Completed |
NCT00655681 -
Prevention of Post Operative Bone Loss in Children
|
N/A | |
Completed |
NCT00798473 -
Zoledronate for Osteopenia in Pediatric Crohn's
|
Phase 3 | |
Active, not recruiting |
NCT00076050 -
Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms
|
Phase 3 | |
Completed |
NCT00226031 -
Optimal Management of Women With Wrist Fractures
|
N/A | |
Enrolling by invitation |
NCT04752098 -
A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method
|
N/A | |
Completed |
NCT04720833 -
Effect of Dried Plum on Bone and Markers of Bone Status in Men
|
N/A | |
Recruiting |
NCT05541432 -
Finding the Optimal Resistance Training Intensity For Your Bones
|
N/A | |
Active, not recruiting |
NCT05405894 -
Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
|
||
Completed |
NCT05457036 -
Evaluation of the Effect of Spry Belt Treatment on Bone Turnover Marker Profile
|
N/A | |
Completed |
NCT04040010 -
The Effects of Bovine Colostrum in Bone Metabolism in Humans
|
N/A | |
Completed |
NCT02731820 -
Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia
|
N/A |